NEW YORK, 4 May 2016 – Hogan Lovells is pleased to announce that Dr. Joseph Eng has joined the firm’s New York office as counsel in its Intellectual Property Media & Technology Practice Group.
Dr. Eng will focus his practice at Hogan Lovells on patent litigation, patent prosecution, and transactional matters. He has represented clients in patent infringement lawsuits in federal district courts across the United States as well as before the International Trade Commission, in cases involving microelectronic devices, semiconductor processing, polymer coatings, optical fibers, medical devices, and respiratory protective devices. Dr. Eng’s litigation experience includes representing major pharmaceutical companies in Hatch-Waxman litigation.
Registered to practice before the United States Patent and Trademark Office, Dr. Eng has worked on numerous patent prosecution matters in the fields of pharmaceuticals, cosmeceuticals, peptide delivery systems, therapeutic uses of neurotoxins, consumer electronics, fuel cells, biofuels, petroleum refining, polymers, and automotive parts.
Dr. Eng’s experience in transactional matters includes licensing, conducting due diligence reviews, advising on asset purchase agreements, and preparing opinions of counsel regarding freedom to operate, patent invalidity, and non-infringement.
Dr. Eng holds a Ph.D. in physical chemistry from Columbia University, a J.D. from Fordham University, and B.S. degrees in both chemistry and physics from the Massachusetts Institute of Technology. Dr. Eng previously worked as a post-doctoral fellow at Exxon’s Corporate Research Center and at Bell Labs, Lucent Technologies. He was also a Member of Technical Staff at Bell Labs, where he was in charge of developing a research program in semiconductor surface characterization.